The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. VolitionRX Ltd shares valued at $21,500 were purchased by Micallef Jacob Vincent on May 19 ’25. At $0.43 per share, Micallef Jacob Vincent acquired 50,000 shares. The insider’s holdings grew to 426,033 shares worth approximately $0.22 million following the completion of this transaction.
Also, Reynolds Cameron John purchased 20,000 shares, netting a total of over 8,730 in proceeds. Following the buying of shares at $0.44 each, the insider now holds 2,319,222 shares.
Before that, Reynolds Cameron John had added 181,818 shares to its account. In a trade valued at $100,000, the President and CEO bought VolitionRX Ltd shares for $0.55 each. Upon closing the transaction, the insider’s holdings increased to 181,818 shares, worth approximately $1.17 million.
As published in their initiating research note from H.C. Wainwright on April 08, 2025, VolitionRX Ltd [VNRX] has been a Buy and the price target has been revised to $2.50. Analysts at The Benchmark Company downgraded the stock from ‘”a Buy”‘ to ‘”a Hold”‘ outlook in a report released in early February. Earlier on March 10, 2021, Cantor Fitzgerald initiated its rating. Their recommendation was “an Overweight” for VNRX stock.
Analyzing VNRX Stock Performance
During the last five days, there has been a surge of approximately 8.69%. Over the course of the year, VolitionRX Ltd shares have dropped approximately -14.75%. Shares of the company reached a 52-week high of $0.6900 on 01/10/25 and a 52-week low of $0.3951 on 05/19/25.
Support And Resistance Levels for VolitionRX Ltd (VNRX)
According to the 24-hour chart, there is a support level at 0.4950, which, if violated, would cause prices to drop to 0.4785. In the upper region, resistance lies at 0.5240. The next price resistance is at 0.5365. RSI (Relative Strength Index) is 54.50 on the 14-day chart, showing neutral technical sentiment.
